Both in Pharmaceuticals
Alto Neuroscience vs Latigo Biotherapeutics
Over the past year ANRO returned −29.4% and LTGO returned −37.0%; their daily moves had a correlation of 0.32.
ANRO −29.4% LTGO −37.0%Growth of $1, one year, split-adjusted
| Metric | ANRO | LTGO |
|---|---|---|
| Price | $22.60 | $13.95 |
| Market cap | $886.9M | $924.9M |
| Today | −3.71% | −10.23% |
| 1 month | −10.7% | −16.4% |
| 6 months | −9.4% | — |
| Year to date | +27.0% | — |
| 1 year | +61.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $225.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 56.0% | — |
| Short % of float | 20.0% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).